Discover trends, market shifts, and competitive outlooks for the proliferative diabetic retinopathy (pdr) industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Proliferative Diabetic Retinopathy (PDR) Market In 2029?

The market size for proliferative diabetic retinopathy (PDR) has experienced rapid expansion in the past few years. It is forecasted to escalate from $2.42 billion in 2024 to a remarkable $2.7 billion in 2025, this corresponds to a compound annual growth rate (CAGR) of 11.6%. The aforementioned growth during the previous period can be traced back to factors such as an increasing prevalence of diabetes, alterations in lifestyle and consumption of unhealthy foods, government led initiatives, and a rise in the number of vision loss incidents related to diabetes.

The market size for proliferative diabetic retinopathy (PDR) is projected to witness speedy expansion in the years to come. The market is expected to surge to $4.02 billion by 2029, with a compound annual growth rate (CAGR) of 10.5%. This significant development in the estimated period can be credited to factors such as an increasing elderly population, heightened public cognizance and learning about diabetes, funds for research and development, and a surge in the demand for combination treatments. Characteristic trends in the projected period encompass advancements in diagnostic technology, novel treatment options, the application of artificial intelligence (AI) for early diagnosis, progress in gene therapy, and cutting-edge retinal imaging.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12911&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Proliferative Diabetic Retinopathy (PDR) Market?

The proliferative diabetic retinopathy (PDR) market is expected to surge as diabetes becomes more rampant. Diabetes, a chronic condition marked by high blood glucose levels, is the predominant cause of proliferative diabetic retinopathy, a disease manageable by various treatments aimed at preserving eyesight and averting further retinal damage. Notably, the National Health Service (NHS) in the UK disclosed in June 2024 that there has been a substantial increase in diabetes instances among individuals below 40 years – with figures rising from 173,166 in 2022 to 216,440 in 2023. This spike underscores a worrisome trend within this demographic, as it evidences a quick uptick in diabetes cases among younger people. Consequently, the escalating prevalence of diabetes acts as a primary driver for the PDR market.

Proliferative Diabetic Retinopathy (PDR) Market Driver: Impact Of Obesity On Proliferative Diabetic Retinopathy (PDR) Market Growth

Which Key Market Segments Comprise the Proliferative Diabetic Retinopathy (PDR) Market and Drive Its Revenue Growth?

The proliferative diabetic retinopathy (PDR) market covered in this report is segmented –

1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy

2) By Mode of Administration: Injectables, Oral, Other Mode Of Administrations

3) By Application: Hospitals, Clinics, Other Applications

Subsegments:

1) By Anti-VEGF Therapy: Aflibercept, Ranibizumab, Bevacizumab

2) By Intraocular Steroids: Triamcinolone Acetonide, Dexamethasone Implant, Fluocinolone Acetonide

3) By Laser Surgery: Focal Laser Photocoagulation, Panretinal Laser Photocoagulation

4) By Vitrectomy: Pars Plana Vitrectomy, Anterior Vitrectomy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12911&type=smp

Which Areas Are Leading Regions in the Proliferative Diabetic Retinopathy (PDR) Market Expansion Across the Globe?

North America was the largest region in the proliferative diabetic retinopathy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in proliferative diabetic retinopathy (PDR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Key Market Trends in theProliferative Diabetic Retinopathy (PDR) Market Over the Coming Years?

In an effort to bolster treatment effectiveness, lessen treatment stress, and better patient results, primary businesses operating in the proliferative diabetic retinopathy market are dedicated to developing novel therapies continuously. For instance, in June 2022, Biogen, an American biotechnology firm, and Samsung Bioepis, a biotechnology company from South Korea, launched Byooviz (ranibizumab-nuna), marking it as the first ophthalmology biosimilar in the United States. These innovations aim to aid patients diagnosed with diabetic macular edema, proliferative diabetic retinopathy, neovascular age-related macular degeneration (wet AMD), and choroidal neovascularization.

View the full report here:

https://www.thebusinessresearchcompany.com/report/proliferative-diabetic-retinopathy-pdr-global-market-report

How Is the Proliferative Diabetic Retinopathy (PDR) Market Conceptually Defined?

Proliferative diabetic retinopathy (PDR) refers to an advanced stage of diabetic eye disease characterized by the growth of abnormal blood vessels in the retina due to prolonged high blood sugar levels. These vessels can lead to retinal bleeding, scarring and vision impairment if left untreated, making regular eye examinations crucial for early detection and management.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12911

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model